CD9 and breast cancer: In this context, it is remarkable that improved methodology for EV isolation and characterization has revealed the existence of “non-classical” exosomes (CD63-, CD81-, CD9- negative exosomes) produced from amphisomes in a breast cancer cell line (71), and thus this new EV type may also be present in the IS.